Yes, doctors can prescribe BPC-157 only where local law allows access to an unapproved or compounded drug , but BPC-157 has no FDA-approved prescription product for any medical condition
In rodent studies, it has shown the ability to accelerate the healing of ulcers, reduce inflammation, and protect the intestinal lining from NSAID-induced damage
Both locations offer custom IV vitamin infusions, vitamin booster shots, NAD+ IV therapy, and peptide therapy
Promotes liver function, immune balance, and cellular resilience*
Egrifta is a Health Canada-approved prescription drug product, dispensed by licensed Canadian pharmacies under a prescriber's order